Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Phibro Animal Health (PAHC) Long-Term Debt Issuances (2016 - 2025)

Phibro Animal Health has reported Long-Term Debt Issuances over the past 13 years, most recently at $62.0 million for Q4 2025.

  • Quarterly results put Long-Term Debt Issuances at $62.0 million for Q4 2025, down 36.73% from a year ago — trailing twelve months through Dec 2025 was $282.0 million (down 51.46% YoY), and the annual figure for FY2025 was $532.0 million, up 92.75%.
  • Long-Term Debt Issuances for Q4 2025 was $62.0 million at Phibro Animal Health, down from $86.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for PAHC hit a ceiling of $300.0 million in Q3 2024 and a floor of -$118.0 million in Q2 2025.
  • Median Long-Term Debt Issuances over the past 5 years was $69.5 million (2021), compared with a mean of $87.9 million.
  • Biggest five-year swings in Long-Term Debt Issuances: surged 488.24% in 2024 and later tumbled 197.52% in 2025.
  • Phibro Animal Health's Long-Term Debt Issuances stood at $77.0 million in 2021, then surged by 140.26% to $185.0 million in 2022, then plummeted by 77.3% to $42.0 million in 2023, then surged by 133.33% to $98.0 million in 2024, then plummeted by 36.73% to $62.0 million in 2025.
  • The last three reported values for Long-Term Debt Issuances were $62.0 million (Q4 2025), $86.0 million (Q3 2025), and -$118.0 million (Q2 2025) per Business Quant data.